To begin to explore the basis for the pro-metastatic effect of FOXA2 in SCLC, we performed pathway analyses on global gene expression changes between FOXA2 KD and safe-targeting controls in the two SCLC cell lines, H1836 and SHP-77. This evidence concerns the gene FOXA2 and small cell lung carcinoma.